中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
22期
1538-1542
,共5页
程哲%代灵灵%曹德飞%吴秋歌%宋永娜%康燕%夏杰%司纪明%陈春艳
程哲%代靈靈%曹德飛%吳鞦歌%宋永娜%康燕%夏傑%司紀明%陳春豔
정철%대령령%조덕비%오추가%송영나%강연%하걸%사기명%진춘염
哮喘%HMGB1蛋白%糖基化终产物,高级%气道炎症
哮喘%HMGB1蛋白%糖基化終產物,高級%氣道炎癥
효천%HMGB1단백%당기화종산물,고급%기도염증
Asthma%HMGB1 protein%Glycosylation end products,advanced%Airway inflammation
目的 探讨HMGB1蛋白和晚期糖基化终产物受体(RAGE)与支气管哮喘发病机制及严重程度的关系.方法 按标准纳入急性发作期哮喘患者64例(哮喘组),健康体检者20名(对照组);哮喘组给予布地奈德与福莫特罗的联合制剂吸入治疗4周.治疗前后分别对各组进行肺功能检测和诱导痰检查,记录第1秒用力呼气容积(FEV1)占预计值的百分比(FEV1%),行诱导痰中中性粒细胞分类计数,酶联免疫吸附法检测诱导痰中HMGB1和RAGE水平.结果 治疗前哮喘组诱导痰中中性粒细胞百分比、HMGB1和RAGE水平均高于对照组(均P<0.01);重度哮喘者诱导痰中中性粒细胞百分比及HMGB1水平均高于轻度哮喘者(均P<0.01),但RAGE水平在轻、中、重度哮喘者之间差异无统计学意义(P>0.05).治疗后哮喘组诱导痰中中性粒细胞百分比及HMGB1和RAGE水平均低于治疗前(均P<0.01);治疗未控制者诱导痰中中性粒细胞百分比、HMGB1和RAGE水平高于完全控制者(均P<0.05);哮喘组HMGB1、RAGE均与FEV1%呈负相关(r=-0.830和r=-0.632,均P<0.01);诱导痰中HMGB1、RAGE均与中性粒细胞百分比呈正相关(r=0.820和r=0.623,均P<0.01);诱导痰中HMGB1水平与RAGE水平呈正相关(r=0.929,P<0.01).结论HMGB1和RAGE参与了哮喘的气道炎症过程,HMGB1与哮喘的严重程度相关;诱导痰中HMGB1和RAGE水平可作为观察疗效的参考指标.
目的 探討HMGB1蛋白和晚期糖基化終產物受體(RAGE)與支氣管哮喘髮病機製及嚴重程度的關繫.方法 按標準納入急性髮作期哮喘患者64例(哮喘組),健康體檢者20名(對照組);哮喘組給予佈地奈德與福莫特囉的聯閤製劑吸入治療4週.治療前後分彆對各組進行肺功能檢測和誘導痰檢查,記錄第1秒用力呼氣容積(FEV1)佔預計值的百分比(FEV1%),行誘導痰中中性粒細胞分類計數,酶聯免疫吸附法檢測誘導痰中HMGB1和RAGE水平.結果 治療前哮喘組誘導痰中中性粒細胞百分比、HMGB1和RAGE水平均高于對照組(均P<0.01);重度哮喘者誘導痰中中性粒細胞百分比及HMGB1水平均高于輕度哮喘者(均P<0.01),但RAGE水平在輕、中、重度哮喘者之間差異無統計學意義(P>0.05).治療後哮喘組誘導痰中中性粒細胞百分比及HMGB1和RAGE水平均低于治療前(均P<0.01);治療未控製者誘導痰中中性粒細胞百分比、HMGB1和RAGE水平高于完全控製者(均P<0.05);哮喘組HMGB1、RAGE均與FEV1%呈負相關(r=-0.830和r=-0.632,均P<0.01);誘導痰中HMGB1、RAGE均與中性粒細胞百分比呈正相關(r=0.820和r=0.623,均P<0.01);誘導痰中HMGB1水平與RAGE水平呈正相關(r=0.929,P<0.01).結論HMGB1和RAGE參與瞭哮喘的氣道炎癥過程,HMGB1與哮喘的嚴重程度相關;誘導痰中HMGB1和RAGE水平可作為觀察療效的參攷指標.
목적 탐토HMGB1단백화만기당기화종산물수체(RAGE)여지기관효천발병궤제급엄중정도적관계.방법 안표준납입급성발작기효천환자64례(효천조),건강체검자20명(대조조);효천조급여포지내덕여복막특라적연합제제흡입치료4주.치료전후분별대각조진행폐공능검측화유도담검사,기록제1초용력호기용적(FEV1)점예계치적백분비(FEV1%),행유도담중중성립세포분류계수,매련면역흡부법검측유도담중HMGB1화RAGE수평.결과 치료전효천조유도담중중성립세포백분비、HMGB1화RAGE수평균고우대조조(균P<0.01);중도효천자유도담중중성립세포백분비급HMGB1수평균고우경도효천자(균P<0.01),단RAGE수평재경、중、중도효천자지간차이무통계학의의(P>0.05).치료후효천조유도담중중성립세포백분비급HMGB1화RAGE수평균저우치료전(균P<0.01);치료미공제자유도담중중성립세포백분비、HMGB1화RAGE수평고우완전공제자(균P<0.05);효천조HMGB1、RAGE균여FEV1%정부상관(r=-0.830화r=-0.632,균P<0.01);유도담중HMGB1、RAGE균여중성립세포백분비정정상관(r=0.820화r=0.623,균P<0.01);유도담중HMGB1수평여RAGE수평정정상관(r=0.929,P<0.01).결론HMGB1화RAGE삼여료효천적기도염증과정,HMGB1여효천적엄중정도상관;유도담중HMGB1화RAGE수평가작위관찰료효적삼고지표.
Objective To explore the relationship between HMGB1 (high mobility group box-1) protein and receptor for advanced glycosylation end products (RAGE) and the nosogenesis and severity of bronchial asthma.Methods Based on the criteria, the asthma group included 64 acute-onset asthma patients while the control group had 20 healthy cases. The asthma group received a 4-week combination inhalation therapy of budesonide and formoterol. Lung functions and induced sputum examinations were conducted before and after treatment. The percentage of a second forced expiratory volume in the predicted value (FEV1%) was recorded. A differential count of neutrophilic leukocyte in reduced sputum was performed. And the sputum levels of HMGB1 and RAGE were detected by ELISA (enzyme linked immunosorbent assay).Results Prior to treatment, the neutrophilic leukocyte percentage and the levels of HMGB1 and RAGE were all higher than those of control group (P<0.01). The induced sputum of severe asthma patients had higher levels of neutrophilic leukocyte percentage and HMGB1 than those of mild cases (P<0.01). But the level of RAGE showed no statistical significance among mild, moderate or severe asthma cases (P>0.05). The post-treatment levels of neutrophilic leukocyte percentage, HMGB1 and RAGE were lower as compared with the pre-treatment ones (P<0.01). These three parameters in uncontrolled cases were higher than those in completely controlled cases (P<0.05);in asthma group, both HMGB1 and RAGE had a negative correlation with FEV1% (r=-0.830, r=-0.632, P<0.01);in induced sputum, both HMGB1 and RAGE had a positive correlation with FEV1% (r=0.820, r=0.623, P<0.01). The levels of HMGB1 and RAGE were positively correlated (r=0.929, P<0.01).ConclusionBoth HMGB1 and RAGE participate in the inflammatory process of asthmatic airway. HMGB1 is correlated with the severity of asthma. And the levels of HMGB1 and RAGE in induced sputum may be employed as reference indices for the observation of therapeutic effects.